Pathophysiology of airway hyperresponsiveness in patients with nasal polyposis

B. Mahut, L. Plantier, B. Chevalier-Bidaud, C. Delclaux (Paris, France)

Source: Annual Congress 2011 - Phenotyping airway diseases
Session: Phenotyping airway diseases
Session type: Oral Presentation
Number: 4715
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Mahut, L. Plantier, B. Chevalier-Bidaud, C. Delclaux (Paris, France). Pathophysiology of airway hyperresponsiveness in patients with nasal polyposis. Eur Respir J 2011; 38: Suppl. 55, 4715

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Aspirin-induced urticaria/angioedema without respiratory symptoms in severe asthmatics with nasal polyposis
Source: Eur Respir J 2002; 20: Suppl. 38, 512s
Year: 2002

Nonallergic rhinitis, sinonasal polyposis and asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 108s
Year: 2003

Effect of mepolizumab on chronic rhinosinusitis symptoms and nasal hypersensitivity in patients with or without nasal polyps
Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities
Year: 2020


Airway inflammation in symptomatic and asymptomatic subjects with and without airway hyperresponsiveness
Source: Eur Respir J 2001; 18: Suppl. 33, 315s
Year: 2001

Allergen-induced nonspecific bronchial hyperresponsiveness in patients with intermittent asthma
Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment
Year: 2009

Peculiarities of cytokine concentration in patients with nasal polyposis and asthmatic triad
Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Year: 2018

Nasal polyposis, analgesics intolerance and asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 428s
Year: 2001

Impact of mepolizumab in severe asthma with nasal polyps
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021


Rhinitis, nasal polyposis and asthma: pathological aspects
Source: ISSN=1025-448x, ISBN=1-904097-19-18, page=115
Year: 2001

Nasal mucosa biopsy in patients with severe bronchial asthma
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009


Airway hyperresponsiveness in adult patients with and without allergies
Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases
Year: 2021


Upper and lower airway inflammation and bronchial hyperresponsiveness in allergic rhinitis children with or without asthma
Source: Annual Congress 2011 - Biological correlates and comorbidities of childhood asthma/allergy
Year: 2011

Involvement of airway eosinophilia and airway hyperresponsiveness in management and therapy for COPD>
Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more
Year: 2020

Treatment of nasal polyposis in aspirine sensitive asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 425s
Year: 2001

Laryngeal vs bronchial hyperresponsiveness
Source: Annual Congress 2005 - PG8 - Vocal cord dysfunction
Year: 2005


Evaluation of bronchial hyperreactivity and hypersensitivity in asthmatics and bronchitis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004

Correlation between bronchial hyperresponsiveness and bronchial inflammation in asthmatic patients
Source: Eur Respir J 2002; 20: Suppl. 38, 49s
Year: 2002

Mepolizumab reduces nasal symptoms in asthmatic patients with chronic rhino-sinusitis and nasal polyposis: a 12 months real-life study
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020